On 11 November 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 150,000 A shares, representing approximately 0.0024% of the previously issued shares (excluding treasury shares). The highest repurchase price per share reached RMB 61.07, and the lowest was RMB 61.01, resulting in a total payment of RMB 9,152,600.

After the repurchase, the number of shares (excluding treasury shares) decreased from 6,375,873,264 to 6,375,723,264. Treasury shares increased from 3,129,010 to 3,279,010, while the total number of issued shares remained at 6,379,002,274.